A comparison of the stem cell characteristics of murine tenocytes and tendon-derived stem cells
- 401 Downloads
Tendon is a commonly injured soft musculoskeletal tissue, however, poor healing potential and ineffective treatment strategies result in persistent injuries and tissue that is unable to perform its normal physiological function. The identification of a stem cell population within tendon tissue holds therapeutic potential for treatment of tendon injuries. This study aimed, for the first time, to characterise and compare tenocyte and tendon-derived stem cell (TDSC) populations in murine tendon. Tenocytes and TDSCs were isolated from murine tail tendon. The cells were characterised for morphology, clonogenicity, proliferation, stem cell and tenogenic marker expression and multipotency. TDSCs demonstrated a rounded morphology, compared with a more fibroblastic morphology for tenocytes. Tenocytes had greater clonogenic potential and a smaller population doubling time compared with TDSCs. Stem cell and early tenogenic markers were more highly expressed in TDSCs, whereas late tenogenic markers were more highly expressed in tenocytes. Multipotency was increased in TDSCs with the presence of adipogenic differentiation which was absent in tenocytes. The differences in morphology, clonogenicity, stem cell marker expression and multipotency observed between tenocytes and TDSCs indicate that at least two cell populations are present in murine tail tendon. Determination of the most effective cell population for tendon repair is required in future studies, which in turn may aid in tendon repair strategies.
KeywordsTendon Tendon-derived stem cell Tenocyte Murine
cluster of differentiation
complementary deoxyribonucleic acid
collagen type II alpha 1
Dulbecco’s modified Eagle’s medium
fatty acid binding protein 4
glyceraldehyde 3-phosphate dehydrogenase
insulin transferrin selenium
mesenchymal stem cell
oil red O
population doubling time
peroxisome proliferator-activated receptor gamma
quantitative real time-polymerase chain reaction
runt-related transcription factor 2
stem cell antigen 1
tendon-derived stem cell
transforming growth factor β
Tendon is prone to injury and degeneration, and this is most often seen in occupational and sporting environments [1, 2, 3]. The healing process for tendon is poorly understood, however it is well documented that tendon tissue is unable to heal effectively resulting in painful and debilitating scar tissue, which is unable to perform its normal physiological function [1, 4]. The current treatment options for damaged or degenerated tendon vary depending on the severity and location of the tendinopathy [5, 6, 7, 8] and include physiotherapy; pharmacotherapies, such as anti-inflammatories; corticosteroid injections; or surgery [5, 6, 9]. However, these treatment strategies are largely ineffective ; therefore, an alternative approach for the management and treatment of tendinopathies is currently being sought.
Tenocytes are tendon-specific fibroblasts and traditionally were thought to be the only cell type present in tendon, however it is now thought that tenocytes account for approximately 95% of the cellular content of tendon, with progenitor cells, endothelial cells and chondrocytes comprising the remaining 5% . Tenocytes are located between collagen fibrils and in the interfascicular matrix and they are responsible for the production of the ECM as well as the repair and maintenance of tendon tissue [10, 11]. The identification of a stem cell population within tendon tissue  holds therapeutic potential for treatment of tendon injuries. Tendon-derived stem cells (TDSCs) have been shown to be clonogenic, multipotent and express stem cell and tenogenic markers [12, 13, 14, 15].
A number of tissue engineering strategies have utilised TDSCs for tendon repair with some successful outcomes [16, 17, 18, 19, 20]. These studies highlight the potential use of TDSCs in tendon repair strategies, however further characterisation of TDSCs is necessary; particularly, the identification and characterisation of different cell populations within tendon tissue. Comparisons of tendon cell populations are lacking in the literature with only two studies comparing tenocytes and TDSC properties in the rabbit  and the horse . These two studies reported conflicting results with large differences found between tenocyte and TDSC populations in the rabbit , but few differences observed in the horse . No studies, to date, have compared tendon cell populations in rodents, despite the plethora of research on TDSCs in rats and mice.
This study aimed to isolate, characterise and compare tenocytes and TDSCs from murine tail tendon. We hypothesised that tenocytes would demonstrate phenotypic differences when compared with TDSCs, particularly differences in stem cell properties.
Isolation of murine tenocytes and TDSCs
HuR floxed embryos were obtained from Dimitris Kontoyiannis, Alexander Fleming Research Centre, Greece  and crossed with Aggrecan A1 Cre mice obtained from George Bou-Gharios, University of Liverpool, UK . Tendon tissue was extracted from the tails of 6–8 week old C57BL/6 mice (HuRfl/flAcan-Cre+/−) which were euthanased for reasons unrelated to this study, and digested for 3 h at 37 °C in 20 ml 375 U/ml collagenase type I and 0.05% trypsin. The resulting cell suspension was strained and then centrifuged at 1200 g for 10 min and the supernatant discarded. The cells were resuspended in complete DMEM (DMEM supplemented with 20% foetal calf serum, 100 U/ml penicillin, 100 μg/ml streptomycin and 2 μg/ml amphotericin B) and counted using a haemocytometer. For tenocyte isolation the cells were seeded at 1 × 105 cells in T25 culture flasks (4 × 103 cells/cm2) [23, 24] and for TDSC isolation the cells were seeded at 100 cells per well of a 6-well plate (10 cells/cm2) [13, 15, 16, 25, 26, 27, 28]. All cells were cultured in complete DMEM at 37 °C, 5% CO2 and 21% O2. TDSCs were cultured for 6–8 days before passaging, whereas tenocytes were cultured for 2–3 days, cells were split 2:1 for subsequent passages. For TDSCs colonies were isolated using cloning cylinders and local application of 0.05% trypsin. All cells were analysed at passage 2–3 .
Cell proliferation assay
Cells at passage 2 were seeded at 10,000 cells in T25 culture flasks at day 0. At 80% confluency the cells were counted and the doubling time calculated using the formula below:
(LOG10(cell number after proliferation)-LOG10(initial seeding density))/LOG10(2) .
Colony formation assay
Cells at passage 2 were seeded at 100 cells/cm2 in 6-well cell culture plates. After 7 days in culture the cells were washed and then fixed with 6% gluteraldehyde and stained with 0.5% crystal violet solution . The cells were washed again and imaged using a biomolecular imager (Typhoon FLA 7000, GE Healthcare) and analysed using ImageQuant software (GE Healthcare) for colony number and size.
Tri-lineage differentiation assays
Cell monolayers were cultured for 21 days in osteogenic (complete DMEM containing 100 nM dexamethasone, 10 mM β-glycerophosphate and 50 mM ascorbic acid)  and adipogenic (complete DMEM containing 1 μM dexamethasone, 100 μM indomethacin, 10 μg/ml insulin and 500 μM IBMX)  induction media. Cell pellets (containing 5 × 105 cells) were cultured for 21 days in chondrogenic (complete DMEM containing 100 nM dexamethasone, 25 μg/ml ascorbic acid, 10 ng/ml TGF-β3 and ITS+ 3 supplement)  induction media. Control cells for all treatments were cultured in complete DMEM. After culturing, the cells were stained with alizarin red and alkaline phosphatase to assess osteogenic differentiation, Oil Red O to assess adipogenic differentiation, or alcian blue for chondrogenic differentiation, as described in the PromoCell MSC application notes (http://www.promocell.com/downloads/application-notes/). Chondrogenic pellets were also paraffin embedded and 4 μm sections taken which were rehydrated and further stained with 1% Alcian blue solution and 0.1% Safranin O solution. In addition, separate cell pellets were digested in 10 U/ml papain solution for 3 h at 60 °C before the total sulphated glycosaminoglycan (sGAG) content was quantified. Dimethylmethylene blue dye was added to each sample and the absorbance read immediately at 570 nm. The sGAG content was calculated from a standard curve produced using chondroitin sulphate standards . RNA was extracted from all assays to analyse lineage-specific gene expression.
RNA extraction and quantitative real time-polymerase chain reaction (qRT-PCR)
RNA was extracted from all cell types by firstly applying Trizol to cell monolayers and using a cell scraper for cell detachment. After vortexing and centrifugation, 50 μg/ml glycoblue and 100% isopropanol were added to the aqueous phase for RNA precipitation. After centrifugation, the pellets were washed in 75% ethanol and resuspended in Tris-EDTA buffer. The quantity and quality of RNA was assessed using a NanoDrop spectrophotometer (Thermo Fisher). 4 U DNase was then added to the samples to remove DNA, after which time an equal volume of phenol:chloroform:IAA was added to each sample. The RNA was then precipitated, centrifuged, washed in ethanol and the RNA quality assessed. cDNA was synthesised in a 25 μl reaction from 1 to 2 μg of total RNA. The conditions for cDNA synthesis were: incubation at 5 min at 70 °C, 60 min at 37 °C and 5 min at 93 °C with M-MLV reverse transcriptase and random-hexamer oligonucleotides (Promega) [35, 36].
Primer sequences for murine genes
Statistical analysis was performed using SPSS (IBM) and SigmaPlot (Systat Software Inc). To ensure data was normally distributed Shapiro Wilk tests were performed. For normally distributed data parametric tests were used for pairwise comparisons. For data which was not normally distributed Log10 data transformations were performed resulting in normally distributed data. For pairwise comparisons paired or independent Student’s t-tests were used. P-values ≤0.05 were taken to be significant.
Tenocyte and TDSC morphology and colony formation
Both cell types were able to form colonies, however these colonies were not homogeneous. Tenocytes generally formed large sparse colonies, whereas TDSCs formed more compact, dense colonies. When quantified tenocytes produced significantly more colonies than TDSCs (Fig. 1b), however colony size was similar between cell types (Fig. 1c).
Tenocyte and TDSC proliferation
Tenocyte and TDSC marker expression
Tenocyte and TDSC tri-lineage differentiation capacity
The ability of tenocytes and TDSCs to differentiate into different cell lineages was analysed by staining, glycosaminoglycan (GAG) assays and qRT-PCR for gene expression analysis.
In this study we have isolated a population of cells in murine tendon that possess some of the traditional hallmarks of a stem cell: the ability to form colonies, the expression of stem cell markers and multipotency . These findings are consistent with the published literature on murine TDSCs [12, 40, 41, 42]. The only discrepancy is the extended population doubling time observed in this study compared with previous reports. This could be explained by variations in cell isolation procedures. In this study we selected a low cell seeding density based on previous work in our group  and other studies [13, 16, 25, 26, 27, 28], however some previous studies have used higher seeding densities. Alternatively, these differences may be due to mouse strain variation as research on murine mesenchymal stem cells (MSCs) has noted considerable variation in stem cell properties, including proliferation, between different strains of mice . In addition, phenotypic differences of MSCs have been observed within certain strains of mice , highlighting the biological variation in murine stem cell populations. The TDSCs isolated in this study also stopped expanding at early passages which made certain assays impossible to perform due to low cell numbers. This may be due to stem cell quiescence, senescence or terminal differentiation and could indicate that these cells are not in fact stem cells but a progenitor cell population. For this reason we were unable to perform chondrogenic differentiation assays on TDSCs. We observed only moderate levels of chondrogenic differentiation for tenocytes which were low compared to reports in human tendon cells  and murine tendon tissue . It is likely that the chondrogenic differentiation potential of TDSCs would be increased compared to tenocytes, as seen for osteogenic and adipogenic differentiation.
To our knowledge, no studies have compared the phenotype of murine tenocytes and TDSCs and we observed a number of phenotypic differences between these two cell populations. Tenocytes and TDSCs demonstrated different cell morphologies and colony forming ability as well as differences in the expression of certain stem cell markers, and some differences in multipotency. TDSCs generally conformed to the criteria of MSCs, as specified by the International Society for Cellular Therapy  (although chondrogenic potential could not be confirmed), whereas tenocytes did not due to a lack of adipogenic differentiation. The primary similarity between tenocytes and TDSCs was the expression of tenogenic markers such as tenascin C and thrombospondin 4, which was expected given that both cell populations were derived from tendon tissue. No studies have previously compared murine tenocytes and TDSCs, however such a comparison has been performed in other species [14, 15]. Our previous work demonstrated no discernible differences between tenocyte and TDSC populations in equine superficial digital flexor tendon, however a restricted differentiation potential was observed for equine TDSCs . In contrast, a comparison of tenocytes and TDSCs in rabbit Achilles and patellar tendon demonstrated considerable differences in stemness between the two cell populations , which are more consistent with our study. The phenotypic differences observed in this study between tenocytes and TDSCs suggest that these cells are distinct populations with differing properties.
TDSCs have been used in a number of tissue engineering strategies to promote tendon healing with some encouraging results in human and animal models [16, 17, 18, 19, 20, 47, 48]. However, many of these studies do not state the exact TDSC isolation method used, or use varying cell seeding densities; in addition, many studies have not fully characterised the cells used for tendon repair. Therefore, it is possible that different tendon cell populations have been used across studies, which were not always defined as TDSCs. It is necessary to determine which tendon cell population is most effective for tendon repair. The increased stemness of murine TDSCs may promote tendon repair, however the poor proliferative potential of these cells is not conducive to tendon regeneration. Alternatively, murine tenocytes which demonstrated improved proliferative potential may provide a more suitable cell population for tendon regeneration. It is possible that the restricted differentiation potential of tenocytes may actually provide a therapeutic benefit during tendon healing by avoiding aberrant differentiation. Analysis of different tendon cell populations in human tendon has not yet been performed, however the presence of multiple tendon cell populations in several species [14, 15] would suggest the presence of more than one tendon cell population in human tendon. A comparison of tendon cell populations in humans is warranted, as well as investigation of the therapeutic potential of different tendon cell populations in vivo, which may highlight alternative, more effective tendon cell populations for human tendon repair strategies.
In conclusion, we have isolated and characterised two distinct tendon cell populations from murine tail tendon with differential properties. These tendon cell populations may provide therapeutic benefit for tendon injury and determination of the most effective cell population for tendon regeneration strategies in both humans and animals requires further investigation.
The authors would like to thank Dr. Simon Tew and Ms. Kirsty Johnson from the University of Liverpool for donation of murine tissue.
This project was funded by the Marjorie Forrest Bequest and by the Institute of Ageing and Chronic Disease at the University of Liverpool, UK. The funding source had no involvement in study design; collection, analysis and interpretation of data; in writing the report; or in the decision to submit the article for publication.
Availability of data and materials
The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.
KJL acquired, analysed and interpreted data. PDC, EJC and EGC-L designed the study. KJL drafted the paper. All authors critically revised the manuscript and read and approved the final submitted version.
Ethics approval and consent to participate
This project used surplus Schedule 1 murine tissue generated under UK Home Office project licence 70/7288 with ethics approval by the University of Liverpool’s Animal Welfare and Ethical Review Body. All animal work was conducted under relevant national and international guidelines: Animal (Scientific Procedures) Act 1986; EU Directive 2010/63/EU.
Consent for publication
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
- 21.Katsanou V, Milatos S, Yiakouvaki A, Sgantzis N, Kotsoni A, Alexiou M, Harokopos V, Aidinis V, Hemberger M, Kontoyiannis DL. The RNA-binding protein Elavl1/HuR is essential for placental branching morphogenesis and embryonic development. Mol Cell Biol. 2009;29:2762–76.CrossRefPubMedPubMedCentralGoogle Scholar
- 25.Cheng B, Ge H, Zhou J, Zhang Q. TSG-6 mediates the effect of tendon derived stem cells for rotator cuff healing. European Rev for Medical and Pharmacol Sci. 2014;18:247–51.Google Scholar
- 29.Nagura I, Kokubu T, Mifune Y, Inui A, Takase F, Ueda Y, Kataoka T, Kurosaka M. Characterization of progenitor cells derived from torn human rotator cuff tendons by gene expression patterns of chondrogenesis, osteogenesis, and adipogenesis. J Orthop Surg Res. 2016;11:40.CrossRefPubMedPubMedCentralGoogle Scholar
- 39.Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8:315–7.CrossRefPubMedGoogle Scholar
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.